First Evaluation of a Novel Pulsatile LVAD: Feasibility and Haemodynamic Impact in Acute Heart Failure
The pVAP reduced the LV mechanical load while increasing systemic pressures and reducing pulmonary pressures. Its functionality as an LVAD is characterised by consistent and predictable performance. Further research is necessary to elucidate the physiological and clinical impact of the device in animals and, subsequently, in humans.
Authors
- Felix Schumacher
- Sara Knigge (ORCID: https://orcid.org/0000-0001-7571-3775)
- Marcelo B. Bastos (ORCID: https://orcid.org/0000-0003-2269-8983)
- Alexander Weymann (ORCID: https://orcid.org/0000-0003-4758-1060)
- Aron‐Frederik Popov (ORCID: https://orcid.org/0000-0003-4226-3004)
- Ali Saad Merzah (ORCID: https://orcid.org/0000-0002-7774-5065)
- Güneş Doğan (ORCID: https://orcid.org/0000-0002-5984-9426)
- Jan D. Schmitto (ORCID: https://orcid.org/0000-0002-0344-1405)
- Bastian Schmack (ORCID: https://orcid.org/0009-0001-5594-0580)
- Oren Malchin
- Liam Schana
- Arjang Ruhparwar
Institutions
- Erasmus MC (NL)
- Medizinische Hochschule Hannover (DE)
- Brentwood Hospital (US)
- Nyenrode Business University (NL)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1002/ehf2.15410
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00